Immuno-PET to Optimize the Dose of Monoclonal Antibodies for Cancer Therapy: How Much Is Enough?

J Nucl Med. 2019 Jul;60(7):899-901. doi: 10.2967/jnumed.119.225854. Epub 2019 May 3.

Author

Raymond M Reilly¹

Affiliation

¹ Departments of Pharmaceutical Sciences and Medical Imaging, University of Toronto, Toronto, Ontario, Canada; and Toronto General Research Institute, University Health Network, Toronto, Ontario, Canada raymond.reilly@utoronto.ca.

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Antibodies, Monoclonal / therapeutic use*
Dose-Response Relationship, Immunologic
Humans
Neoplasms / diagnostic imaging*
Neoplasms / immunology
Neoplasms / therapy*
Positron-Emission Tomography*

Substances

Antibodies, Monoclonal